LFMD Q2 2025 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q2 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$62M+22.8% YoY

Gross Profit

$55M88.1% margin

Operating Income

-$906,772-1.5% margin

Net Income

-$2M-3.3% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-5.3%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$74M

Total Liabilities

$73M

Stockholders' Equity

-$2M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$51M	+22.8%
Gross Profit	$55M	$46M	+20.1%
Operating Income	-$906,772	-$6M	+85.6%
Net Income	-$2M	-$7M	+69.8%

Revenue Segments

Product and Services

$4M100%